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Juvenile hyaline fibromatosis: an unusual clinical presentation 
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Introduction 
Juvenile hyaline fibromatosis (JHF) was first 
described by Murray in 1873 as molluscum fibrosum 
[1]. It is a rare disease with recessive autosomal 
heredity that is characterized by abnormal growth of 
hyalinized fibrous tissue [2-4]. Juvenile hyaline 
fibromatosis is clinically characterized by tumors, 
bone lesions, joint contractures, gingival 
hyperplasia, and normal intelligence [1, 5, 6]. Most 
tumors involve head, back, and extremities. The 
lesions are painless, but cosmetically unacceptable 
[4]. It is most commonly diagnosed in early 
childhood, even though there are some reports of 
new diagnosis in adult life [5]. It is a progressive 
disease and the manifestations tend to be additive 
with age. There is no gender or ethnic predilection. 
One-third of affected children are siblings and 
several have been born to consanguineous parents 
[6, 7]. Variable penetrance is present and two distinct 
forms of JHF has been postulated: a localized form 
with very slow growth and a diffuse form with large 
and rapidly growing tumors [4, 5]. The treatment is 
not satisfactory. Early surgical excision is 
recommended, but recurrences are frequent [8]. We 
report a patient with juvenile hyaline fibromatosis 
without gingival hyperplasia and onset at 8 years old 
with late progression in adolescence.  
 
Case Synopsis 
A 23-year-old man, born of unrelated parents, 
presented with multiple tumors. At 8 years of age, he 
developed a single nodule on the face. At 15 years, 
he began to develop other multiple nodules 
involving the head, back, abdomen, extremities, and 
perianal area. He also reported stiffness and 
limitation in moving the shoulders. The nodules 
were uncomfortable and interfered with sleep. 
Parents, brothers and sisters were healthy and 
denied any dermatologic disease.  
On dermatologic examination, he exhibited multiple 
firm tumors variable in size. Most were located on the 
face, back, abdomen and extremities (Figure 1). 
These lesions were also restricting the function of the 
joints, mainly the shoulders. There were no oral 
findings (Figure 1). Computed tomography showed 
osteolytic lesions in the shoulders and hip related to 
tumor compression.  
Abstract 
Juvenile hyaline fibromatosis is a recessive 
autosomal hereditary disorder characterized by 
abnormal growth of hyalinized fibrous tissue. Its 
clinical presentation is marked by tumors of the skin, 
bone lesions, joint contractures, and gingival 
hyperplasia. We report a localized form of juvenile 
hyaline fibromatosis, a rare disease with several cases 
reported in the worldwide literature. A 23-year-old 
man presented with multiple tumors, joint 
contractures, and osteolytic bone lesions, but 
without gingival hyperplasia in one year of follow-up. 
Although, the onset of this condition is commonly in 
early childhood with progression, his unusual clinical 
presentation began at eight years of age with late 
progression in adolescence.   
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Several tumors were excised from the back and have 
not recurred (Figure 2). Histopathological findings 
showed poorly circumscribed masses of 
eosinophilic, hyalinized, periodic acid-Schiff-positive 
and diastase-resistant material in dermis and 
subcutaneous tissue. A hypocellular spindle cell 
proliferation, with hyperchromatic nuclei was seen 
without evidence of mitosis (Figure 3). Congo red 
stain was negative. Immunohistochemical studies 
showed that the spindle cells were positive for 
collagen III, vimentin, smooth muscle actin, HHF35, 
and beta catenin (not shown). A panel of special 
stains and immunostains with results was listed in 
Tables 1, 2. 
 
 
 
Figure 1. Multiple tumorous skin lesions involving forehead 
and back. Gingival hyperplasia is absent. 
 
Figure 2. One-year follow-up after first surgical excision, without 
recurrence to the present. 
Table 1. Staining results of biopsy. 
Matrix stains Result 
PAS with diastase Positive
Congo red Negative
Table 2. Immunohistochemical stains of biopsy. 
Immunohistochemistry of 
cellular component Result 
Colagen III Positive
Vimentin Positive
Smooth muscle actin Positive 
HHF 35 Positive
Beta catenin Positive 
AE1AE3 Negative 
S100 Negative
CD34 Negative
Caldesmon Negative 
Ciclin D1 Negative
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Case Discussion 
Juvenile hyaline ﬁbromatosis was ﬁrst reported by 
Murray in 1873 as molluscum ﬁbrosum, but the 
current name was provided by Kitano in 1976. It is a 
rare recessive autosomal hereditary disease that 
arises from abnormalities of the gene ANTXR2 
located in chromosome 4q21. Variable penetrance is 
described and patients can express partial disease. 
Several pathogenetic mechanisms have been 
proposed including impaired synthesis of 
procollagen or tropocollagen, increased synthesis of 
glycosaminoglycans by fibroblasts, and impaired 
collagen IV metabolism. More recently, decreased 
type III collagen metabolism and a secondary 
increase in type I collagen metabolism have been 
suggested [4, 9]. The authors speculated that this 
abnormal collagen metabolism leads to instability 
and intracellular accumulation, and may explain the 
clinical manifestations of JHF. 
We report a localized form with limited cutaneous 
involvement, slow growth, and normal life 
expectancy. The diagnosis was based on the 
presence of typical skin tumors, osteolytic bone 
lesions, joint contractures, and histopathological 
findings. He did not exhibit gingival hyperplasia. 
However, he may develop these complications in the 
future.  
The first signs are often lesions on the skin and soft 
tissue, although joint manifestations could be 
primary. Juvenile hyaline fibromatosis is not a 
disorder known to undergo malignant 
transformation and the related primary morbidity is 
a result of joint contractures that limit movement, 
and may result in patients becoming wheelchair-
bound in early adulthood. Large cutaneous nodules 
may develop ulceration and secondary infection or 
pain [1, 6, 10]. Gingival overgrowth may result in 
poor oral hygiene and dental infections [3]. 
A similar condition, infantile systemic hyalinosis, 
should be considered in the differential diagnosis. It 
is characterized by the above findings with further 
visceral involvement. The main difference is the age 
of presentation and the prognosis. Carriers of this 
diffuse form are usually dead by early childhood, 
owing to intractable diarrhea because of hyalinized 
growths in the gastrointestinal tract. Many authors 
consider that JHF and ISH are in a spectrum of one 
disorder, hyaline fibromatosis syndrome, with 
differing penetrance and phenotypic expression [1]. 
Figure 3. Histopathological findings: hyalinized PAS-positive 
and diastase resistant material, permeating monomorphic 
hypocellular spindled cells proliferation. H&E, A) 40×; B) 100×; C) 
400×. 
A 
B
C 
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Other conditions in the differential diagnosis that 
should be included are: Winchester syndrome, 
neurofibromatosis, nodular amyloidosis, and Farber 
disease. Winchester syndrome is characterized by 
joint contractures, osteoporosis, corneal opacities, 
and dwarfism. Skin nodules are uncommon and 
there is no deposition of hyaline matrix. 
Neurofibromatosis is also commonly characterized 
by dermal and soft tissue tumors, although joint 
contractures and gingival hypertrophy are not usual. 
Furthermore, neural differentiation is consistently 
absent in the skin lesions of juvenile hyaline 
fibromatosis [1]. Farber disease is a disorder of lipid 
metabolism characterized by nodular swelling 
around the joints, short stature, and delayed mental 
development. Nodular amyloidosis shows a 
hyalinized and paucicellular matrix as does JHF, but 
Congo red is positive. Congo red stain was negative 
in our case, distinguishing it from amyloidosis. The 
pattern of hyaline material and the monomorphic 
fusocellular proliferation with low mitotic rate 
supports the diagnosis of JHF. 
Conclusion 
Juvenile hyaline fibromatosis is a rare disease and 
requires multidisciplinary care. It is particularly 
important for the dermatologist to recognize the 
early development of nodules to allow surgical 
intervention and familial genetic counselling with an 
aim to minimize the impact of the disease. The main 
treatment for JHF is surgical excision of 
subcutaneous nodules, although local recurrence is 
common. There is a limited response to intralesional 
corticosteroid injections in early stages [9]. The 
functional prognosis for patients with joint 
contractures is poor. Symptomatic treatment for 
joint contracture, including capsulotomy, 
corticosteroids, ACTH and/or physiotherapy may be 
attempted [4]. Gingivectomy is also commonly 
suggested for the treatment of gingival hypertrophy 
[3]. 
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